Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. 1997

H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
Institut Pasteur, Tunis, Tunisia.

Serum samples from 33,363 healthy people in Tunisia have been tested for serological markers of hepatitis B, C and delta viruses (HBV, HCV and HDV). Hepatitis B surface antigen (HBsAg) was detected in 6.5% of sera. The overall seroprevalence of HBV was 37.5%. Vertical and perinatal transmission of HBV in the first 3 months of life occurred in only 0.4% of 177 mother and child pairs. HBV seroprevalence was 10.7% in infants under 5 years old and increased with age rapidly till 25 years of age and then more slowly in adulthood, reaching 54% for people aged over 40 years. HBsAg seropositivity varied throughout the country, ranging from 3% to 13% with higher prevalences in the south and central-west regions. Overall seroprevalences for HDV and HCV were 17.7% and 0.4%, respectively. HDV superinfection occurred later than HBV and increased with age in parallel with HBV. Overall, HCV and HBV infections had different geographical distributions throughout the country. The study confirmed the high prevalence of HBV infection in Tunisia; it occurs mainly in children and teenagers, and vertical and perinatal transmission of HBV does not appear to be significant. HDV superinfection is quite common in Tunisia and occurs in almost 44% of individuals infected with HBV. In contrast, seroprevalence of HCV in the Tunisian general population was low (0.4%). These results indicate differences in the distribution of the viruses and/or different routes of transmission.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003699 Hepatitis D INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Amazon Black Fever,Black Fever, Amazon,Delta Hepatitis,Delta Infection,Delta Superinfection,Hepatitis, Delta,Labrea Disease,Infection, Delta,Superinfection, Delta,Delta Superinfections,Disease, Labrea,Diseases, Labrea,Fever, Amazon Black,Hepatitides, Delta,Infections, Delta,Labrea Diseases,Superinfections, Delta
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis

Related Publications

H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
October 2016, Current opinion in virology,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
January 2014, Hepatitis research and treatment,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
January 1985, Bulletin de la Societe de pathologie exotique et de ses filiales,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
December 2003, Journal of tropical pediatrics,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
February 2008, Journal of medical virology,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
July 1990, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
June 1985, International journal of epidemiology,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
January 2006, Journal of medical virology,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
January 1991, Przeglad epidemiologiczny,
H Triki, and N Said, and A Ben Salah, and A Arrouji, and F Ben Ahmed, and A Bouguerra, and S Hmida, and R Dhahri, and K Dellagi
January 1987, Clinical therapeutics,
Copied contents to your clipboard!